Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer

This publication has 20 references indexed in Scilit:

• Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model
  Proteomics, 2005
• Blue silver: A very sensitive colloidal Coomassie G‐250 staining for proteome analysis
  Electrophoresis, 2004
• Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
  Proceedings of the National Academy of Sciences, 2003
• Biology of Prostate-Specific Antigen
  Journal of Clinical Oncology, 2003
• Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer
  International Journal of Clinical Oncology, 2002
• Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
  JAMA, 2002
• Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology
  JNCI Journal of the National Cancer Institute, 2001
• The current state of two-dimensional electrophoresis with immobilized pH gradients
  Electrophoresis, 2000
• Lung cancer
  The Lancet, 2000
• An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions
  Lung Cancer, 1999